[ Contents | Search | Next | Previous | Up ]
From: Ora McCreary
Date: 07 Oct 2010
Time: 13:15:32 -0500
Remote Name: 64.95.16.243
Does anyone know the latest on pagoclone? Tom Weidig has posted some information in his blog in the past few months - http://thestutteringbrain.blogspot.com/search?q=pagoclone . Particularly the July 12 post (http://thestutteringbrain.blogspot.com/2010/07/breaking-news-pagoclone-did-not-meet.html includes an excerpt of a press release by Endo Pharmaceuticals, stating, "Although the study did not meet its pre-specified criteria for success, there were some trends of interest that Endo will look at more closely by conducting additional analyses of the data." Does anyone have any further information on the results of the study, or what are Endo's plans for further testing or development of the drug? Is there any reason for optimism that we'll hear more of pagoclone in the future? Or does this mean that pagoclone is dead?